dna-repair ercc1 gene polymorphisms in epithelial ovarian cancer and relation to platinum resistance and survivaldna修复ercc1基因多态性在卵巢癌上皮和铂电阻和生存.pdfVIP

dna-repair ercc1 gene polymorphisms in epithelial ovarian cancer and relation to platinum resistance and survivaldna修复ercc1基因多态性在卵巢癌上皮和铂电阻和生存.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
dna-repair ercc1 gene polymorphisms in epithelial ovarian cancer and relation to platinum resistance and survivaldna修复ercc1基因多态性在卵巢癌上皮和铂电阻和生存

Journal of Cancer Therapy, 2011, 2, 140-147 doi:10.4236/jct.2011.22016 Published Online June 2011 (http://www.SciRP.org/journal/jct) DNA-Repair ERCC1 Gene Polymorphisms in Epithelial Ovarian Cancer and Relation to Platinum Resistance and Survival 1,2 3 1,2 Karina Dahl Steffensen , Marianne Waldstrøm , Anders Jakobsen 1Department of Oncology, Vejle Hospital, Vejle, Denmark; 2Institute of Regional Health Services Research, University of Southern Denmark, Odense C, Denmark; 3Pathology, Vejle Hospital, Vejle, Denmark. Email: Karina.Dahl.Steffensen@slb.regionsyddanmark.dk Received March 3rd, 2011; revised April 20th, 2011; accepted April 30th, 2011. ABSTRACT Objectives: Excision repair cross-complementation group 1 (ERCC 1) is a key DNA repair gene in the nucleotide exci- sion repair pathway which is activated in the repair of intra- and interstrand DNA crosslink caused by platinum-based treatment. Two single nucleotide polymorphisms (SNPs) of the ERCC 1 gene, codon 118 C/T and C8092A , have been reported to be functional, but the influence on platinum resistance and survival is not yet clear. The primary aim of the present study was to investigate whether the two SNPs were associated with resistance to standard combination car- boplatin and paclitaxel chemotherapy and the potential prognostic impact in newly diagnosed ovarian cancer patients. Methods : Serum samples from 202 patients with newly diagnosed ovarian cancer were assessed for ERCC 1 SNP geno- typing using real time PCR. All patients were treated with first line carboplatin/paclitaxel chemotherapy. Results : There were no correlation between the ERCC1 118 C/T and C8092A genotypes and platinum resistance (P = 0.79 and P = 0.36, respectively). Furthermore, the results showed no association to progression free survival (P = 0.18 and P = 0.16, respectively) or o

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档